Effects of central neurokinin-1 receptor antagonism on cocaine- and opiate-induced locomotor activity and self-administration behaviour in rats

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 1, 2006, Pages 94-101

  Placenza, Franca M ^a   Fletcher, Paul J ^a,b   Vaccarino, Franco J ^a   Erb, Suzanne ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Cocaine; GR82334; Locomotor activity; NK 1 receptors; Opiates; Self administration; Substance P

Indexed keywords

COCAINE; DIAMORPHINE; MORPHINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; OPIATE; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN];

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELF ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; REINFORCEMENT; REWARD; TRAINING;

ANIMALS; COCAINE; INJECTIONS, INTRAVENTRICULAR; LOCOMOTION; MALE; NARCOTICS; PHYSALAEMIN; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; SELF ADMINISTRATION;

ANIMALIA;

EID: 33745642499     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.04.011     Document Type: Article

References (40)

1. Bannon M.J., Elliot P.J., Alpert J.E., Goedert M., Iversen S.D., and Iversen L.L. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurons. Nature 306 (1983) 791-792
2. Boix F., Sandor P., Nogueira P.J., Huston J.P., and Schwarting R.K. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64 4 (1995) 1045-1055
3. Bozarth M.A., and Wise R.A. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28 5 (1981) 551-555
4. Cador M., Rivet J.M., Kelley A.E., Le Moal M., and Stinus L. Substance P, neurotensin and enkaphalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res 486 (1989) 357-363
5. Deutch A.Y., Maggio J.E., Bannon M.J., Kalivas P.W., Tam S.E., Goldstein M., et al. Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides 6 (1985) 113-122
6. de Wit H., and Wise R.A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol 31 4 (1977) 195-203
7. Di Ciano P., and Everitt B.J. The GABA(B) receptor agonist baclofen attenuates cocaine-and heroin-seeking behavior by rats. Neuropsychopharmacology 28 3 (2003) 510-518
8. Eison A.S., Iversen S.D., Sandberg B.E.B., Watson S.P., Hanley M.R., and Iversen L.L. Substance P analogue, DiMe-C7: evidence for stability in the rat brain and prolonged central action. Science 215 (1982) 188-190
9. Elliott P.J., and Iversen S.D. Behavioural effects of tachykinins and related peptides. Brain Res 381 (1986) 68-76
10. Elliott P.J., Alpert J.E., Bannon M.J., and Iversen S.D. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Res 363 (1986) 145-147
11. Elliott P.J., Nemeroff C.B., and Kilts C.D. Evidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbens. Brain Res 385 2 (1986) 379-382
12. Elliott P.J., Mason G.S., Stephens-Smith M., and Hagan R.M. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides 19 2 (1991) 119-126
13. Elliott P.J., Mason G.S., Graham E.A., Turpin M.P., and Hagan R.M. Modulation of the rat mesolimbic dopamine pathway by neurokinins. Behav Brain Res 51 1 (1992) 77-82
14. Gadd C.A., Murtra P., De Felipe C., and Hunt S.P. Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J Neurosci 23 23 (2003) 8271-8280
15. Gysling K., and Wang R.Y. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res 277 1 (1983) 119-127
16. Higgins G.A., Joharchi N., Wang Y., Corrigall W.A., and Sellers E.M. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol. Brain Res 640 1-2 (1994) 246-254
17. Holzhauer-Oitzl M.-S., Boucke K., and Huston J.P. Reinforcing properties of substance P in the lateral hypothalamus revealed by conditioned place preference. Pharmacol Biochem Behav 28 (1987) 511-515
18. Hutson P.H., Patel S., Jay M.T., and Barton C.L. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist. Eur J Pharmacol 484 1 (2004) 57-64
19. Kalivas P.W., and Miller J.S. Substance P modulation of dopamine in the nucleus accumbens. Neurosci Lett 48 1 (1984) 55-59
20. Kelly P.H., and Iversen S.D. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40 1 (1976) 45-56
21. Kelley A.E., Stinus L., and Iversen S.D. Behavioral activation induced in the rat by substance P infusions into the VTA: implication of dopaminergic A10 neurons. Neurosci Lett 11 (1979) 335-339
22. Kelley A.E., Stinus L., and Iversen S.D. Interactions between d-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat. Behav Brain Res 1 1 (1980) 3-24
23. Kraft M., Ahluwahlia S., and Angulo J.A. Neurokinin-1 receptor antagonists block acute cocaine-induced horizontal locomotion. Ann N Y Acad Sci 937 (2001) 132-139
24. Martin T.J., Walker L.E., Sizemore G.M., Smith J.E., and Dworkin S.I. Within-session determination of dose-response curves for heroin self-administration in rats: comparison with between-session determination and effects of naltrexone. Drug Alcohol Depend 41 2 (1996) 93-100
25. Minabe Y., Emori K., Toor A., Stutzmann G.E., and Ashby Jr. C.R. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study. Synapse 22 1 (1996) 35-45
26. Murtra P., Sheasby A.M., Hunt S.P., and De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405 6783 (2000) 180-183
27. Murtra P, Sheasby A, Hunt SP, De Felipe C. Loss of rewarding effects of morphine and amphetamine, but not cocaine, in mice with disruption of the substance P receptor (NK1) gene. Program No. 658.5. Abstract Viewer/Itinerary Planner. Washington, DC, Society for Neuroscience; 2000b. Online.
28. Naranjo J.R., and Del Rio J. Locomotor activation induced in rodent by substance P and analogues. Blockade of the effect of substance P by met-enkephalin antiserum. Neuropharmacology 23 10 (1984) 1167-1171
29. Negus S.S., Henriksen S.J., Mattox A., Pasternak G.W., Portoghese P.S., Takemori A.E., et al. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 265 3 (1993) 1245-1252
30. Nikolaus S., Huston J.P., and Hasenohrl R.U. Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor. Eur J Pharmacol 370 2 (1999) 93-99
31. Overton P., Elliott P.J., Hagan R.M., and Clark D. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur J Pharmacol 213 1 (1992) 165-166
32. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1982), Academic Press, New York
33. Placenza F.M., Fletcher P.J., Rotzinger S., and Vaccarino F.J. Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats. Psychopharmacology 177 1-2 (2004) 111-120
34. Placenza F.M., Vaccarino F.J., Fletcher P.J., and Erb S. Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behavior. Neurosci Lett 390 1 (2005) 42-47
35. Ripley T.L., Gadd C.A., De Felipe C., Hunt S.P., and Stephens D.N. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 43 8 (2002) 1258-1268
36. Rocío M., Carrera A., Schulteis G., and Koob G.F. Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone. Psychopharmacology 144 (1999) 111-120
37. Shippenberg T.S., Bals-Kubik R., and Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265 1 (1993) 53-59
38. Stäubli U., and Huston J.P. Central action of substance P: possible role in reward. Behav Neural Biol 43 1 (1985) 100-108
39. Yokel R.A., and Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: Implication for a dopamine theory of reward. Science 187 (1975) 547-549
40. Yokel R.A., and Wise R.A. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48 (1976) 311-318